Who
Julie B. Kampf
Director
Company insider
Files Form 4 as: Director, Jupiter Neurosciences; Director, Marizyme.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 7 Jun 2022
- Last trade
- 2 Jun 2026
- Last filed
- 13 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jun 2026filed 4 Jun 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jun 2025filed 13 Jul 2026 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Code M | —82,875 | filing |
| 2 Jun 2025filed 13 Jul 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —82,875 at $0.00 | filing |
| 2 Jun 2025filed 13 Jul 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —82,875 at $0.00 | filing |
| 2 Jun 2025filed 13 Jul 2026 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Code M | —82,875 | filing |
| 7 Jun 2022filed 9 Jun 2022 | Marizymeoption or derivative | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.